COMMUNIQUÉS West-GlobeNewswire

Annual General Meeting in ALK-Abelló A/S on 12 March 2018

13/02/2018 - 13:55

Copenhagen, 2018-02-13 13:55 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): The annual general meeting of ALK-Abelló A/S will take place on Monday 12 March 2018 at 16:00 (CET) at ALK-Abelló A/S, 1 [...]

Spark Therapeutics to Host Conference Call on Tuesday, Feb. 20 at 8:30 a.m. ET to Discuss 2017 Results and Recent Business Highlights

13/02/2018 - 13:30

PHILADELPHIA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on [...]

KemPharm to Present at the RBC Capital Markets 2018 Global Healthcare Conference

13/02/2018 - 13:30

Corporate Updates and Clinical Progress to be Highlighted CORALVILLE, Iowa, Feb. 13, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a clinical-stage specialty pharmaceutical company focused on the discovery [...]

OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas® Tests

13/02/2018 - 13:30

GAITHERSBURG, Md., Feb. 13, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that it has entered into a global supply agreement to use Thermo Fisher Scientific’s real-time PCR technology in the [...]

Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1

13/02/2018 - 13:15

BOSTON, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP ), today announced that management will host a conference call and webcast slide presentation on Thursday, March 1, at 4:30 p.m. ET to [...]

Shire Provides Regulatory Progress Update for Key Pipeline Programs Targeting Rare Disease

13/02/2018 - 13:01

Shire Provides Regulatory Progress Update for Key Pipeline Programs Targeting Rare Disease - U.S. FDA Grants Orphan Drug Designation for Investigational SHP647 for Treatment of Pediatric Patients with Moderately to [...]

RedHill Biopharma to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call on February 22, 2018

13/02/2018 - 13:00

TEL-AVIV, Israel and RALEIGH, N.C., Feb. 13, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

CampDoc.com Partners with CCC to Offer Integrated Camp Electronic Health Record Solution

13/02/2018 - 13:00

ANN ARBOR, Mich., Feb. 13, 2018 (GLOBE NEWSWIRE) -- CampDoc.com, the leading electronic health record system for camps , has partnered with CCC, a provider of fully integrated software solutions for member-centric [...]

Natus to Present at Raymond James 39th Annual Institutional Investors Conference

13/02/2018 - 13:00

PLEASANTON, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jonathan Kennedy, Executive Vice-President and Chief Financial Officer will present at the Raymond [...]

Amunix CEO to deliver keynote address on ProTIA, Amunix’s novel immuno-oncology technology, at the Biologics & Biosimilars Congress Europe (March 2018)

13/02/2018 - 13:00

MOUNTAIN VIEW, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. (Amunix), a biopharmaceutical company focused on the discovery and development of novel immuno-oncology therapeutics, announced today that [...]

Initiation of stock buyback program

13/02/2018 - 12:59

Please read the full announcement in the attached PDF http://prlibrary-eu.nasdaq.com/Resource/Download/c28caac0-5533-4304-8726-857202a7a695

Avivagen to Seek Approval from TSX Venture Exchange for Extension of Warrants

13/02/2018 - 12:30

OTTAWA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]

Invitation to Novozymes' annual shareholders' meeting 2018

13/02/2018 - 12:29

Please see attached for further details http://prlibrary-eu.nasdaq.com/Resource/Download/9277d98c-4398-4d3f-9b11-2ba43f3518da http://prlibrary-eu.nasdaq.com/Resource/Download/72dd8aea-22b4-483d-9b4e-9c66000bafdb

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

13/02/2018 - 12:01

FIT Biotech Oy Company release February 13, 2018 at 1:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Digirad Corporation to Release 2017 Fourth Quarter and Year-End Financial Results on February 23, 2018

13/02/2018 - 12:00

SUWANEE, Ga., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD ) will release financial results for its fourth quarter and year ended December 31, 2017, before the market opens on Friday, February 23 [...]

CV Sciences, Inc. to Present and Exhibit as Silver Sponsor at Natural Products Expo West 2018 in Anaheim, California, March 7-11, 2018

13/02/2018 - 11:45

LAS VEGAS, Feb. 13, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that its industry dominating [...]

Sanofi : Information concerning the total number of voting rights and shares

13/02/2018 - 11:11

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/1cb41595-1a62-4ba3-8cef-ecfd855d267e

Sanofi : Informations relatives au nombre total de droits de vote et d'actions

13/02/2018 - 11:11

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/92a363dc-7bd0-4339-a43f-78bc215823f3

Cytovance® Biologics, Inc. announces completion of first batch in new state-of-the-art 1000L microbial facility

13/02/2018 - 11:00

OKLAHOMA CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, announces completion of first batch in [...]